These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 33404109)

  • 1. Psoriasis: Recent progress in molecular-targeted therapies.
    Honma M; Hayashi K
    J Dermatol; 2021 Jun; 48(6):761-777. PubMed ID: 33404109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular Pathogenesis of Psoriasis and Biomarkers Reflecting Disease Activity.
    Honma M; Nozaki H
    J Clin Med; 2021 Jul; 10(15):. PubMed ID: 34361983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and Safety of Biologics for Psoriasis and Psoriatic Arthritis and Their Impact on Comorbidities: A Literature Review.
    Kamata M; Tada Y
    Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32121574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In the Real World: Infections Associated with Biologic and Small Molecule Therapies in Psoriatic Arthritis and Psoriasis.
    Siegel SAR; Winthrop KL
    Curr Rheumatol Rep; 2019 Jun; 21(7):36. PubMed ID: 31172303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biologics for psoriasis: What is new?
    Özyurt K; Ertaş R; Atasoy M
    Dermatol Ther; 2019 May; 32(3):e12916. PubMed ID: 30972872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of the IL-23/IL-17 Axis in Psoriasis and Psoriatic Arthritis: The Clinical Importance of Its Divergence in Skin and Joints.
    Boutet MA; Nerviani A; Gallo Afflitto G; Pitzalis C
    Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29425183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of psoriasis: janus kinases inhibitors and biologics for the interleukin-23/Th17 axis.
    Sun C; Xia J
    Minerva Med; 2020 Jun; 111(3):254-265. PubMed ID: 32166932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current and emerging biologic and small molecule systemic treatment options for psoriasis and psoriatic arthritis.
    Lin CP; Merola JF; Wallace EB
    Curr Opin Pharmacol; 2022 Dec; 67():102292. PubMed ID: 36228472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New JAK inhibitors for the treatment of psoriasis and psoriatic arthritis.
    D'Urso DF; Chiricozzi A; Pirro F; Calabrese L; Caldarola G; Fossati B; De Simone C; Peris K
    G Ital Dermatol Venereol; 2020 Aug; 155(4):411-420. PubMed ID: 32545945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New generation biologics for the treatment of psoriasis and psoriatic arthritis. State of the art and considerations about the risk of infection.
    Ceccarelli M; Venanzi Rullo E; Berretta M; Cacopardo B; Pellicanò GF; Nunnari G; Guarneri C
    Dermatol Ther; 2021 Jan; 34(1):e14660. PubMed ID: 33301216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of interleukin-17, interleukin-23 and the TH17 cell pathway in the treatment of psoriatic arthritis and psoriasis.
    Mease PJ
    Curr Opin Rheumatol; 2015 Mar; 27(2):127-33. PubMed ID: 25599143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biologics that inhibit the Th17 pathway and related cytokines to treat inflammatory disorders.
    Balato A; Scala E; Balato N; Caiazzo G; Di Caprio R; Monfrecola G; Raimondo A; Lembo S; Ayala F
    Expert Opin Biol Ther; 2017 Nov; 17(11):1363-1374. PubMed ID: 28791896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Immunologic Role of IL-17 in Psoriasis and Psoriatic Arthritis Pathogenesis.
    Blauvelt A; Chiricozzi A
    Clin Rev Allergy Immunol; 2018 Dec; 55(3):379-390. PubMed ID: 30109481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New biologics for psoriasis and psoriatic arthritis.
    Rozenblit M; Lebwohl M
    Dermatol Ther; 2009; 22(1):56-60. PubMed ID: 19222517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The TNF/IL-23/IL-17 axis-Head-to-head trials comparing different biologics in psoriasis treatment.
    Ten Bergen LL; Petrovic A; Krogh Aarebrot A; Appel S
    Scand J Immunol; 2020 Oct; 92(4):e12946. PubMed ID: 32697374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apremilast mechanism of action and application to psoriasis and psoriatic arthritis.
    Schafer P
    Biochem Pharmacol; 2012 Jun; 83(12):1583-90. PubMed ID: 22257911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tailored treatment options for patients with psoriatic arthritis and psoriasis: review of established and new biologic and small molecule therapies.
    Elyoussfi S; Thomas BJ; Ciurtin C
    Rheumatol Int; 2016 May; 36(5):603-12. PubMed ID: 26892034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are psoriasis and psoriatic arthritis the same disease? The IL-23/IL-17 axis data.
    Sakkas LI; Bogdanos DP
    Autoimmun Rev; 2017 Jan; 16(1):10-15. PubMed ID: 27666819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biologics and Small Molecule Agents in Allergic and Immunologic Skin Diseases.
    Kaufman BP; Alexis AF
    Curr Allergy Asthma Rep; 2018 Aug; 18(10):55. PubMed ID: 30171358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Updated therapies for the management of Psoriatic Arthritis.
    Toussi A; Maverakis N; Le ST; Sarkar S; Raychaudhuri SK; Raychaudhuri SP
    Clin Immunol; 2020 Nov; 220():108536. PubMed ID: 32681979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.